Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
- Conditions
- Percutaneous Coronary Intervention
- First Posted Date
- 2023-06-08
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- CathWorks Ltd.
- Target Recruit Count
- 1924
- Registration Number
- NCT05893498
- Locations
- 🇺🇸
University of California San Diego Health, La Jolla, California, United States
🇺🇸VA- Long Beach Healthcare, Long Beach, California, United States
🇺🇸Keck Medicine of USC, Los Angeles, California, United States
Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease
- Conditions
- Multi Vessel Coronary Artery Disease
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- CathWorks Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT03455244
- Locations
- 🇯🇵
Gifu Heart Center, Gifu, Japan
FFRangio Accuracy vs. Standard FFR
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- CathWorks Ltd.
- Target Recruit Count
- 382
- Registration Number
- NCT03226262
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸Columbia University Medical Center/NewYork Presbyterian Hospital, New York, New York, United States
🇺🇸St. Francis Hospital, Roslyn, New York, United States
Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study
- Conditions
- CAD - Coronary Artery Disease
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- CathWorks Ltd.
- Target Recruit Count
- 184
- Registration Number
- NCT03005028
- Locations
- 🇮🇱
Rabin Medical Center, Petah Tiqva, Israel